CARCINOMA, NEUROENDOCRINE
Clinical trials for CARCINOMA, NEUROENDOCRINE explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NEUROENDOCRINE trials appear
Sign up with your email to follow new studies for CARCINOMA, NEUROENDOCRINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ADCT-701 enters first human trial for rare cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called ADCT-701 in about 70 adults with rare neuroendocrine tumors, adrenal cancer, or malignant nerve sheath tumors that have not responded to standard treatments. The drug is given through an IV and aims to deliver a cancer-killing agent …
Matched conditions: CARCINOMA, NEUROENDOCRINE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
Gene-Guided drug dosing could improve treatment for rare cancer
Disease control Recruiting nowThis study aims to find the best dose of the drug belinostat for people with high-grade neuroendocrine carcinomas based on their genetic makeup. Some people have a gene variant that affects how quickly their body processes belinostat, so adjusting the dose may reduce side effects…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Scientists launch lifelong study to unravel mysteries of rare neuroendocrine cancers
Knowledge-focused Recruiting nowThis study follows 300 adults with neuroendocrine tumors (including adrenocortical carcinoma) over their lifetime to understand how these rare cancers behave. Participants provide blood, urine, and tumor samples, and have yearly check-ups. The goal is to gather information and sa…
Matched conditions: CARCINOMA, NEUROENDOCRINE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC